Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus

Hormone and Metabolic Research

Volumn 37, Issue 5, 2005, Pages 326-330

  Swislocki, Arthur ^a   Noth, R ^b   Hallstone, A ^b   Kyger, E ^b   Triadafilopoulos, C ^b  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Autonomic nervous system; C peptide; Diabetes mellitus; Pancreatic exocrine function; Plasma amylase; Secretin

Indexed keywords

ALBUMIN; AMYLASE; C PEPTIDE; PANCREAS ENZYME; SECRETIN;

ACINAR CELL; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTROCARDIOGRAM; ENDOCRINE FUNCTION; ENZYME THERAPY; GLUCOSE TOLERANCE; GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROVOCATION TEST; RR INTERVAL; URINARY EXCRETION;

AMYLASES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PANCREAS; SECRETIN;

EID: 21244471512     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861478     Document Type: Article

References (48)

1. Jarotzky AJ. Uber die Veranderungen in der Grosse und in Bau der Pankreaszellen mit einigen Arten der Inanition. Virchow's Arch Patho Anat 1899; 156: 409-429
2. Williams J, Goldfine I. The insulin-pancreatic acinar axis. Diabetes 1985; 34: 980-986
3. Lohr M, Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 1987; 30: 757-762
4. Nakanishi K, Kobayashi T, Miyashita H et al. Relationships among residual β-cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 1993; 42: 196-203
5. Nakanishi K, Kobayashi T, Miyashita H et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol 1994; 89: 762-766
6. Frier BM, Faber OK, Binder C, Elliott HL. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia 1978; 14: 301-304
7. Lankisch PG, Manthey G, Otto J et al. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982; 25: 211-216
8. Frier BM, Adrian TE, Saunders JHB, Bloom SR. Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus. Clinica Chimica Acta 1980; 105: 297-300
9. Frier BM, Saunders JHB, Wormsley KG, Bouchier IAD. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976; 17: 685-691
10. El Newihi H, Dooley CP, Saad C, Staples J, Zeidler A, Valenzuela JE. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci 1988; 33: 705-710
11. Landin-Olsson M, Borgstrom A, Blom L, Sundkvist G, Lernmark A. The Swedish Childhood Diabetes Group: Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. Pancreas 1990; 5: 241-247
12. Lorini R, Cortona L, Scotta MS, Melzi d'Eril GV, Severi F. Exocrine pancreatic function in children and adolescents with insulin-dependent diabetes mellitus. Diab Res Clin Pract 1990; 8: 263-267
13. Yajnik CS, Sahasrabudhe RA, Naik SS et al. Exocrine pancreatic function (serum immunoreactive trypsin, fecal chymotrypsin, and pancreatic isoamylase) in Indian diabetics. Pancreas 1990; 5: 631-638
14. Dandona P, Elias E, Beckett AG. Serum trypsin concentrations in diabetes mellitus. Brit Med J 1978; 2: 1125
15. Moffat A, Marks V, Gamble DR. Serum immunoreactive trypsin concentrations in diabetic children. J Clin Pathol 1980; 33: 871-875
16. Moller-Petersen J, Kjaergard JJ, Mourits-Andersen HT, Svendsen KN, Dideriksen K, Ditzel J. Serum concentration of cathodic trypsin-like immunoreactivity and pancreatic isoamylase in insulin-dependent diabetes mellitus. Acta Med Scand 1982; 211: 459-462
17. Adrian TE, Barnes AJ, Bloom SR. Hypotrypsinaemia in diabetes mellitus. Clin Chim Acta 1979; 97: 213-216
18. Moles KW, Kerr JI, Armstrong E, Hayes JR, Buchanan KD. Serum concentrations of trypsin-like immunoreactivity and pancreatic isoamylase in insulin dependent diabetic patients. Pancreas 1988; 3: 135-139
19. Foo Y, Rosalki SB, Ramdial L, Mikhailidis D, Dandona P. Serum isoamylase activities in diabetes mellitus. J Clin Pathol 1980; 33: 1102-1105
20. Junglee D, de Albarran R, Katrak A, Freedman DB, Beckett AG, Dandona P. Low pancreatic lipase in insulin-dependent diabetics. J Clin Pathol 1983; 36: 200-202
21. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and the categories of glucose intolerance. Diabetes 1979; 28: 1039-1057
22. de Fronzo RA. The triumvirate: beta-cell, muscle, liver. A collusion responsible for non-insulin-dependent diabetes mellitus. Diabetes 1988; 37: 667-687
23. Brannon PM, Hirschi K, Korc M. Effects of epidermal growth factor, insulin, and insulin-like growth factor 1 on rat pancreatic acinar cells cultured in serum-free medium. Pancreas 1988; 3: 41-48
24. MacGregor IL, DeVeney C, Way LW, Meyer JH. The effect of acute hyperglycemia on meal-stimulated gastric, biliary, and pancreatic secretion and serum gastrin. Gastroenterology 1976; 70: 197-202
25. Unger RM, Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet-cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985; 28: 119-121
26. Arky RA. Diet and diabetes. In: Rifkin H, Raskin P (eds). Diabetes Mellitus, volume 5. Bowie, Maryland: Robert J. Brady Co, 1981
27. Dubick MA, Conteas CN, Billy HT, Majumdar APN, Geokas MC. Raised serum concentrations of pancreatic enzymes in cigarette smokers. Gut 1987; 28: 330-335
28. Florholmen J, Burhol PG, Jorde R, Waldum HL. The effect of graded doses of secretin on serum trypsin, serum pancreatic amylase, serum insulin, plasma somatostatin, and plasma pancreatic polypeptide in man. Scand J Gastroenterol 1984; 19: 24-30
29. Adler G, Bedlinger C. Hormones as regulators of pancreatic secretion in man. Eur J Clin Invest 1990; 20 (suppl 1 ): S27-S32
30. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta 1969; 26: 437-444
31. Ceska M, Hultman E, Ingelman BG. A new method for determination of alpha-amylase. Experientia 1969; 25: 555-556
32. Ceska M, Brown B, Birath K. Ranges of alpha-amylase activities in human serum and urine and correlations with some other alpha-amylase methods. Clin Chim Acta 1969; 26: 445-453
33. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Diabetes 1984; 33: 486-494
34. Blix PM, Boddie-Willis C, Landau RL, Rochman H, Rubenstein AH. Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions. J Clin Endocrinol Metab 1982; 54: 574-580
35. Krause U, von Erdmann B, Atzpodien W, Beyer J. C-peptide measurement: a simple method for the improvement of specificity. J Immunoassay 1981; 2: 33-44
36. Kumar MS, Schumacher OP, Deodar SD. Measurement of serum c-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics. Am J Clin Path 1980; 74: 78-82
37. Gatling W, Row DJF, Hill RD. Microalbuminuria: an appraisal of assay techniques and urine collection procedures for measuring urinary albumin at low concentration. In: Mogensen CE (ed). The kidney and hypertension in diabetes mellitus. Boston: Martinus Nijhoff, 1988: 41-50
38. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Brit Med J 1982; 285: 916-918
39. Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill Book Company, 1962
40. Del Rosario MAF, Fitzgerald JF, Gupta SK, Croffie JM. Direct measurement of pancreatic enzymes after stimulation with secretin versus secretin plus cholecystokinin. J Pediatr Gastroenterol Nutr 2000; 31: 28-32
41. Pfefferkorn MD, Fitzgerald JF, Croffie JM, Gupta SK, Caffrey HM. Direct measurement of pancreatic enzymes: A comparison of secretogogues. Dig Dis Sci 2002; 47: 2211-2216
42. Sonwalkar SA, Holbrook IB, Phillips I, Kelly SM. A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function. Aliment Pharmacol Ther 2003; 17: 467-471
43. Luth S, Teyssen S, Forssmann K, Kolbel C, Krummenauer F, Singer MV. Fecal elastase-1 determination: 'Gold standard' of indirect pancreatic function tests? Scand J Gastroenterol 2001; 10: 1092-1099
44. Icks A, Haastert B, Giani G, Rathmann W. Low fecal elastase-1 in type 1 diabetes mellitus. Z Gastroenterol 2001; 29: 823-830
45. Hardt PD, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E, Bretzel RG, Zekorn T, Klor HU. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37: 105-110
46. Chey WY, Chang TM. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology 2001; 1: 320-335
47. Shimizu K, Shiratori K, Hayashi N, Fujiwara T, Horikoshi H. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus. Pancreas 2000; 21: 421-426
48. Kawamori R, Katsura M, Ishida S, Yamasaki Y, Tujii M, Kawano S, Kamada T. Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice. J Diabet Complic 1995; 9: 69-73